Xintiandi: Announcement on the company passing the GMP compliance inspection of pharmaceuticals
Newland Pharmaceutical: Special report on the funding raised and actual usage in the first half of 2024.
Newland Pharmaceutical: Verification opinion of Huatai United Securities Co., Ltd. on the permanent supplement of working capital by using part of the over-raised funds by Xintiandi Pharmaceutical Co., Ltd.
Newland Pharmaceutical: Announcement of the Supervisory Board's resolution.
Newland Pharmaceutical: Huatai United Securities Co., Ltd.'s tracking report on New World Pharmaceuticals Co., Ltd. for the first half of 2024.
Newland Pharmaceutical: Announcement Regarding the Permanent Supplement of Working Capital Using Part of the Over- Raised Funds.
Newland Pharmaceutical: Board of directors resolution announcement.
Newland Pharmaceutical: Huatai United Securities Co., Ltd.'s verification opinion on the partial lifting of restrictions and listing of previously issued shares of Xintiandi Pharmaceutical Co., Ltd. before its initial public offering.
Xintiandi: Announcement of Resolutions of the First Meeting of the 6th Board of Directors
Xintiandi: Announcement of Resolutions of the First Meeting of the 6th Board of Supervisors
Xintiandi: Investor Relations Activity Record Form
Xintiandi: Independent Director Nominee Statements and Commitments (Jia Faliang)
Xintiandi: Announcement of Resolutions of the 14th Meeting of the Fifth Board of Supervisors
Xintiandi: Special instructions from Grant Thornton Accounting Firm (Special General Partnership) on the occupation of non-operating capital of Xintiandi Pharmaceutical Co., Ltd. and other related capital transactions
Xintiandi: Independent Director Nominee's Statement and Commitment (Wang Jingbao)
Xintiandi: 2023 Independent Director Debriefing Report (Wang Jingbao)
Xintiandi: Huatai United Securities Co., Ltd.'s inspection opinions on Xintiandi Pharmaceutical Co., Ltd.'s use of some idle own funds to purchase bank structured deposits or wealth management products
Xintiandi: Board Nomination Committee's Review Opinions on Nominating Non-Independent Directors and Independent Director Candidates
Xintiandi: Huatai United Securities Co., Ltd.'s 2023 annual follow-up report on Xintiandi Pharmaceutical Co., Ltd.
Xintiandi: Announcement of Resolutions of the 18th Meeting of the Fifth Board of Directors
No Data
No Data